Find a Clinical Trial
The clinical trials at Gundersen offer the same cutting-edge treatments as those at other top medical research hospitals – and often much sooner than they’re available to everyone.
Showing 10 of 89 trials
S2302
Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study
Adult (18-64)
Older adult (65+)
S1905
Study to Test AKR1C3-Activated Prodrug OBI-3424 (OBI-3424) in Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL)
Adult (18-64)
Older adult (65+)
REC-4881-221
A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation
Adult (18-64)
Older adult (65+)
TP-CA-002
GEMINI-NSCLC: NSCLC Biomarker Study
Adult (18-64)
Older adult (65+)
A211901
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Adult (18-64)
Older adult (65+)
A021806
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
Adult (18-64)
Older adult (65+)
NCI-2017-00009
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
Adult (18-64)
Older adult (65+)
TAS-120-206
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors
Adult (18-64)
Older adult (65+)
NCI-2020-04334
EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients
Adult (18-64)
Older adult (65+)
OCU410-101
Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy
Adult (18-64)
Older adult (65+)